Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract
Laparoscopic Ultrasound (LUS) is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer (esophageal, gastric, pancreatic and liver cancer). When a suspect lesion is visualized during LUS a biopsy should be provided in order to differentiate between benign and malignant lesions. A new system for LUS guided biopsy has been developed, but how often these biopsies are clinically relevant (i.e. changing patient management)and how reliable are these biopsies are unknown.
The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer.
|Esophageal Cancer Gastric Cancer Pancreatic Cancer Liver Cancer|
|Study Design:||Time Perspective: Prospective|
|Official Title:||Prospective Evaluation of the Impact of Laparoscopic Ultrasound (LUS) Guided Fine-Needle Aspiration or Tru-Cut Biopsy in Patients With Upper GI Tract Cancer|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00511264
|Department of Surgery, Odense University Hospital|
|Odense, Denmark, 5000|
|Principal Investigator:||Michael B Mortensen, MD, Ph.D.||Department of Surgery, Odense University Hospital|